Development of a CZE Method for the Determination of Olmesartan Medoxomil in Tablets
Authors:
- 23 October 2007
- journal article
- Published by Springer Nature in Chromatographia
- Vol. 66 (11-12) , 929-933
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Why not using capillary electrophoresis in drug analysis?Electrophoresis, 2006
- Capillary electrophoresis in pharmaceutical analysis (A review)Pharmaceutical Chemistry Journal, 2006
- A Review of the Structural and Functional Features of Olmesartan Medoxomil, An Angiotensin Receptor BlockerJournal of Cardiovascular Pharmacology, 2005
- Trends in quality in the analytical laboratory. II. Analytical method validation and quality assuranceTrAC Trends in Analytical Chemistry, 2004
- Trends in quality in the analytical laboratory. I. Traceability and measurement uncertainty of analytical resultsTrAC Trends in Analytical Chemistry, 2004
- The Role of Olmesartan Medoxomil in the Management of HypertensionDrugs, 2004
- Application of capillary zone electrophoresis to the screening of some angiotensin II receptor antagonistsElectrophoresis, 2002
- Real-Time Monitoring of Metabolic Reactions by Microdialysis in Combination with Tandem Mass Spectrometry: Hydrolysis of CS-866 in Vitro in Human and Rat Plasma, Livers, and Small IntestinesAnalytical Biochemistry, 2000
- Derivatization in capillary electrophoresisJournal of Chromatography A, 1998
- Nonpeptide Angiotensin II Receptor Antagonists: Synthesis, Biological Activities, and Structure−Activity Relationships of Imidazole-5-carboxylic Acids Bearing Alkyl, Alkenyl, and Hydroxyalkyl Substituents at the 4-Position and Their Related CompoundsJournal of Medicinal Chemistry, 1996